Putney

company

About

Putney develops high quality veterinary medicine, helping vets and pet owners to evaluate the best treatment options for their pet patients.

  • 51 - 100

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$9.30M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2006
Number Of Employee
51 - 100
Operating Status
Active

Putney is a pharmaceutical company specializing in the development of high quality drugs for pets. They focus on developing generics for frequently used drugs where cost is a barrier to prescribing, compliance or use. They offer our prescription drugs for sale to companion animal veterinarians —veterinarians who treat pets.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$25.35M
Putney has raised a total of $25.35M in funding over 2 rounds. Their latest funding was raised on Jun 23, 2014 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 23, 2014 Series Unknown $16.05M 1 Detail
Aug 31, 2013 Debt Financing $9.30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Putney is funded by 1 investors. Advantage Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Advantage Capital Series Unknown